Atherosclerotic plaque ruptures rarely occur distally to the most stenotic region; rather, they occur in proximal regions distinguished by a specific transcriptional signature, reports a new analysis that highlights the importance of future therapeutic targets such as metallopeptidase-9 (MMP-9).